Total Payments
$7,515
2024 Payments
$1,712
Companies
30
Transactions
220
Medicare Patients
3,186
Medicare Billing
$204,996
Payment Breakdown by Category
Food & Beverage$7,515 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,515 | 220 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,046 | 43 | $0 (2024) |
| Allergan, Inc. | $988.55 | 17 | $0 (2022) |
| Alcon Vision LLC | $527.32 | 18 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $523.17 | 21 | $0 (2024) |
| BIOTISSUE HOLDINGS INC. | $460.69 | 9 | $0 (2024) |
| Bausch & Lomb, a division of Bausch Health US, LLC | $432.55 | 14 | $0 (2021) |
| Bausch & Lomb Americas Inc. | $393.93 | 12 | $0 (2024) |
| Oyster Point Pharma, Inc. | $392.73 | 10 | $0 (2024) |
| Eyevance Pharmaceuticals LLC | $383.22 | 7 | $0 (2021) |
| Aerie Pharmaceuticals, Inc. | $372.01 | 9 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,712 | 42 | BIOTISSUE HOLDINGS INC. ($437.60) |
| 2023 | $1,342 | 41 | AbbVie Inc. ($298.37) |
| 2022 | $1,382 | 50 | ABBVIE INC. ($470.30) |
| 2021 | $754.56 | 25 | Alcon Vision LLC ($175.30) |
| 2020 | $638.02 | 27 | Allergan, Inc. ($161.40) |
| 2019 | $1,172 | 27 | Allergan Inc. ($343.47) |
| 2018 | $513.90 | 8 | Allergan Inc. ($247.87) |
All Payment Transactions
220 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Glaukos Corporation | iDose (Device) | Food and Beverage | Cash or cash equivalent | $39.22 | General |
| Category: Glaucoma | ||||||
| 12/19/2024 | Alcon Vision LLC | Rocklatan (Drug) | Food and Beverage | In-kind items and services | $28.17 | General |
| Category: Ophthalmology | ||||||
| 12/16/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug) | Food and Beverage | In-kind items and services | $25.31 | General |
| Category: Ophthalmology | ||||||
| 12/09/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $26.62 | General |
| Category: EYE CARE | ||||||
| 12/02/2024 | Bausch & Lomb Americas Inc. | XIIDRA (Drug), MIEBO | Food and Beverage | In-kind items and services | $20.92 | General |
| Category: Ophthalmology | ||||||
| 11/26/2024 | Dompe US, Inc. | OXERVATE (Drug) | Food and Beverage | In-kind items and services | $32.40 | General |
| Category: SOLUTION/ DROPS | ||||||
| 11/11/2024 | BIOTISSUE HOLDINGS INC. | — | Food and Beverage | Cash or cash equivalent | $127.96 | General |
| 11/04/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $32.36 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 10/31/2024 | Dompe US, Inc. | OXERVATE (Drug) | Food and Beverage | In-kind items and services | $25.27 | General |
| Category: SOLUTION/ DROPS | ||||||
| 10/22/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $13.50 | General |
| Category: EYE CARE | ||||||
| 10/18/2024 | Oyster Point Pharma, Inc. | TYRVAYA (Drug), Ryzumvi | Food and Beverage | In-kind items and services | $27.17 | General |
| Category: Dry eyes | ||||||
| 10/17/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $28.94 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 10/05/2024 | Harrow Eye, LLC | VEVYE (Drug) | Food and Beverage | In-kind items and services | $25.44 | General |
| Category: OPTOMETRY | ||||||
| 10/03/2024 | BIOTISSUE HOLDINGS INC. | — | Food and Beverage | In-kind items and services | $127.96 | General |
| 09/17/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $11.70 | General |
| Category: EYE CARE | ||||||
| 09/16/2024 | BIOTISSUE HOLDINGS INC. | — | Food and Beverage | Cash or cash equivalent | $20.00 | General |
| 08/22/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $37.31 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 08/21/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $16.43 | General |
| Category: EYE CARE | ||||||
| 07/29/2024 | Bausch & Lomb Americas Inc. | VYZULTA (Drug) | Food and Beverage | In-kind items and services | $22.20 | General |
| Category: Ophthalmology | ||||||
| 07/22/2024 | BIOTISSUE HOLDINGS INC. | — | Food and Beverage | Cash or cash equivalent | $19.44 | General |
| 07/01/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $12.97 | General |
| Category: EYE CARE | ||||||
| 06/25/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug) | Food and Beverage | In-kind items and services | $118.18 | General |
| Category: Ophthalmology | ||||||
| 06/04/2024 | Bausch & Lomb Americas Inc. | XIIDRA (Drug), MIEBO | Food and Beverage | In-kind items and services | $18.31 | General |
| Category: Ophthalmology | ||||||
| 05/30/2024 | Harrow Eye, LLC | VEVYE (Drug) | Food and Beverage | In-kind items and services | $16.00 | General |
| Category: OPTOMETRY | ||||||
| 05/23/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $21.56 | General |
| Category: EYE CARE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 1,206 | 1,542 | $359,325 | $74,620 |
| 2022 | 13 | 960 | 1,258 | $287,315 | $61,543 |
| 2021 | 12 | 668 | 727 | $145,830 | $43,423 |
| 2020 | 10 | 352 | 389 | $70,574 | $25,409 |
Total Patients
3,186
Total Services
3,916
Medicare Billing
$204,996
Procedure Codes
49
All Medicare Procedures & Services
49 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 226 | 257 | $69,390 | $17,120 | 24.7% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 176 | 178 | $68,530 | $15,658 | 22.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 100 | 100 | $49,500 | $10,782 | 21.8% |
| 92136 | Measurement of corneal curvature and depth of eye | Office | 2023 | 150 | 450 | $52,990 | $8,450 | 15.9% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 56 | 56 | $25,480 | $5,546 | 21.8% |
| 92250 | Photography of the retina | Office | 2023 | 167 | 167 | $35,905 | $4,318 | 12.0% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 92 | 93 | $18,600 | $4,300 | 23.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 35 | 35 | $11,200 | $3,050 | 27.2% |
| 92133 | Imaging of optic nerve | Office | 2023 | 64 | 64 | $8,640 | $1,706 | 19.7% |
| 92134 | Imaging of retina | Office | 2023 | 43 | 43 | $6,020 | $1,262 | 21.0% |
| 92002 | New patient problem focused exam of visual system | Office | 2023 | 21 | 21 | $5,460 | $1,069 | 19.6% |
| 92020 | Exam of the internal drainage system of eye | Office | 2023 | 35 | 36 | $3,060 | $787.07 | 25.7% |
| 92025 | Ct scan of cornea | Office | 2023 | 12 | 13 | $3,100 | $326.34 | 10.5% |
| 76514 | Ultrasound scan of cornea to determine thickness | Office | 2023 | 29 | 29 | $1,450 | $247.20 | 17.0% |
| 92012 | Established patient problem focused exam of visual system | Office | 2022 | 206 | 234 | $62,145 | $14,895 | 24.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 105 | 105 | $51,975 | $11,466 | 22.1% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 124 | 128 | $48,380 | $11,188 | 23.1% |
| 92136 | Measurement of corneal curvature and depth of eye | Office | 2022 | 134 | 396 | $47,550 | $7,908 | 16.6% |
| 92083 | Exam of visual field with extended testing | Office | 2022 | 81 | 82 | $16,400 | $3,824 | 23.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 34 | 35 | $11,375 | $2,964 | 26.1% |
| 92250 | Photography of the retina | Office | 2022 | 82 | 82 | $17,630 | $2,200 | 12.5% |
| 92004 | New patient complete exam of visual system | Office | 2022 | 20 | 20 | $9,035 | $2,139 | 23.7% |
| 92134 | Imaging of retina | Office | 2022 | 56 | 56 | $7,840 | $1,720 | 21.9% |
| 92133 | Imaging of optic nerve | Office | 2022 | 59 | 60 | $8,100 | $1,528 | 18.9% |
| 92002 | New patient problem focused exam of visual system | Office | 2022 | 14 | 14 | $3,640 | $985.08 | 27.1% |
About Dr. Christopher Sek, OD
Dr. Christopher Sek, OD is a Optometrist healthcare provider based in Bellaire, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/24/2018. The National Provider Identifier (NPI) number assigned to this provider is 1134606015.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christopher Sek, OD has received a total of $7,515 in payments from pharmaceutical and medical device companies, with $1,712 received in 2024. These payments were reported across 220 transactions from 30 companies. The most common payment nature is "Food and Beverage" ($7,515).
As a Medicare-enrolled provider, Sek has provided services to 3,186 Medicare beneficiaries, totaling 3,916 services with total Medicare billing of $204,996. Data is available for 4 years (2020–2023), covering 49 distinct procedure/service records.
Ad
Practice Information
- Specialty Optometrist
- Location Bellaire, TX
- Active Since 07/24/2018
- Last Updated 07/24/2018
- Taxonomy Code 152W00000X
- Entity Type Individual
- NPI Number 1134606015
Products in Payments
- LUMIGAN (Drug) $635.07
- XIIDRA (Drug) $598.55
- TYRVAYA (Drug) $392.73
- Flarex (Drug) $383.22
- RESTASIS (Drug) $366.84
- OZURDEX (Drug) $329.81
- Cequa (Drug) $317.51
- VYZULTA (Drug) $284.37
- VUITY (Drug) $284.20
- RESTASIS MULTIDOSE (Drug) $234.13
- DURYSTA (Drug) $164.48
- rhopressa (Drug) $157.49
- EYLEA (Biological) $144.41
- TOTAL30 (Device) $138.94
- AcrySof IQ PanOptix (Device) $132.86
- RXSIGHT INJECTOR HANDPIECE (Device) $132.08
- Rhopressa (Drug) $124.85
- Acuvue (Device) $124.81
- MIEBO (Drug) $116.11
- Rocklatan (Drug) $115.67
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Optometrist Doctors in Bellaire
Dr. Jill Autry, O.d, O.D
Optometrist — Payments: $231,640
Optometrist $231,640
Aamena Kazmi, O.d, O.D
Optometrist — Payments: $13,333
Optometrist $13,333
Dr. Christopher Allee, O.d, O.D
Optometrist — Payments: $8,882
Optometrist $8,882
Amanda Bachman, O.d, O.D
Optometrist — Payments: $8,761
Optometrist $8,761
Darcy Seaton, Od, OD
Optometrist — Payments: $8,403
Optometrist $8,403
Julie Ngo, O.d, O.D
Optometrist — Payments: $7,330
Optometrist $7,330